Comparison of the discriminative stimulus and response rate effects of Δ9-tetrahydrocannabinol and synthetic cannabinoids in female and male rats

Drug and Alcohol Dependence

Volumn 172, Issue , 2017, Pages 51-59

  Wiley, Jenny L ^a   Lefever, Timothy W ^a   Marusich, Julie A ^a   Craft, Rebecca M ^b  

^a RTI INTERNATIONAL   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Drug discrimination; Response rate; Sex differences; Synthetic cannabinoids; Tetrahydrocannabinol

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 (1 NAPHTHOYL) 1 PENTYLINDOLE; A 834735; CANNABINOID; CP 47 497; DRONABINOL; RIMONABANT; SYNTHETIC CANNABINOID; UNCLASSIFIED DRUG; 1-PENTYL-3-(1-NAPHTHOYL)INDOLE; BENZOXAZINE DERIVATIVE; CP 47497; CYCLOHEXANOL DERIVATIVE; INDOLE DERIVATIVE; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG EFFECT; DRUG POTENCY; FEMALE; MALE; NONHUMAN; RAT; RESPONSE TIME; SENSITIVITY ANALYSIS; SEX DIFFERENCE; ANIMAL; COMPARATIVE STUDY; DISCRIMINATION LEARNING; DOSE RESPONSE; DRUG EFFECTS; PERCEPTIVE DISCRIMINATION; SEXUAL DEVELOPMENT;

ANIMALS; BENZOXAZINES; CANNABINOIDS; CYCLOHEXANOLS; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRONABINOL; FEMALE; INDOLES; MALE; MORPHOLINES; NAPHTHALENES; RATS; SEX CHARACTERISTICS;

EID: 85010468568     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2016.11.035     Document Type: Article

References (45)

1. 9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication. Neurosci. Biobehav. Rev. 16 (1992), 55–62.
2. Becker, J.B., Hu, M., Sex differences in drug abuse. Front. Neuroendocrinol. 29 (2008), 36–47.
3. Becker, J.B., Koob, G.F., Sex differences in animal models: Focus on addiction. Pharmacol. Rev. 68 (2016), 242–263.
4. 9-tetrahydrocannabinol exposure. Br. J. Pharmacol. 161 (2010), 103–112.
5. Castaneto, M.S., Gorelick, D.A., Desrosiers, N.A., Hartman, R.L., Pirard, S., Huestis, M.A., Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend. 144 (2014), 12–41.
6. Castelhano-Carlos, M.J., Baumans, V., The impact of light, noise, cage cleaning and in-house transport on welfare and stress of laboratory rats. Lab. Anim. 43 (2009), 311–327.
7. Castelli, M.P., Fadda, P., Casu, A., Spano, M.S., Casti, A., Fratta, W., Fattore, L., Male and female rats differ in brain cannabinoid CB1 receptor density and function and in behavioural traits predisposing to drug addiction: effect of ovarian hormones. Curr. Pharm. Des. 20 (2014), 2100–2113.
8. Cooper, Z.D., Haney, M., Investigation of sex-dependent effects of cannabis in daily cannabis smokers. Drug Alcohol Depend. 136 (2014), 85–91.
9. Craft, R.M., Wakley, A.A., Tsutsui, K.T., Laggart, J.D., Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat. J. Pharmacol. Exp. Ther. 340 (2012), 787–800.
10. Craft, R.M., Kandasamy, R., Davis, S.M., Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of delta(9)-tetrahydrocannabinol in the rat. Pain 154 (2013), 1709–1717.
11. Craft, R.M., Marusich, J.A., Wiley, J.L., Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?. Life Sci. 92 (2013), 476–481.
12. Extance, K., Goudie, A.J., Inter-animal olfactory cues in operant drug discrimination procedures in rats. Psychopharmacology (Berl.) 73 (1981), 363–371.
13. Fattore, L., Spano, M.S., Altea, S., Angius, F., Fadda, P., Fratta, W., Cannabinoid self-administration in rats: sex differences and the influence of ovarian function. Br. J. Pharmacol. 152 (2007), 795–804.
14. Fattore, L., Spano, M.S., Altea, S., Fadda, P., Fratta, W., Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones. Br. J. Pharmacol. 160 (2010), 724–735.
15. Fogel, J.S., Kelly, T.H., Westgate, P.M., Lile, J.A., Sex differences in the subjective effects of oral delta-THC in cannabis users. Pharmacol. Biochem. Behav., 2016, 10.1016/j.pbb.2016.01.007 [Epub ahead of print].
16. Gatch, M.B., Forster, M.J., Delta9-tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2/Spice. Behav. Pharmacol. 25 (2014), 750–757.
17. Grim, T.W., Morales, A.J., Gonek, M.M., Wiley, J.L., Thomas, B.F., Endres, G.W., Sim-Selley, L.J., Selley, D.E., Negus, S.S., Lichtman, A.H., Stratification of cannabinoid 1 receptor (CB1R) agonist efficacy: manipulation of CB1R density through use of transgenic mice reveals congruence between in vivo and in vitro assays. J. Pharmacol. Exp. Ther. 359 (2016), 329–339.
18. Harte-Hargrove, L.C., Dow-Edwards, D.L., Withdrawal from THC during adolescence: sex differences in locomotor activity and anxiety. Behav. Brain Res. 231 (2012), 48–59.
19. Hill, M.N., McLaughlin, R.J., Bingham, B., Shrestha, L., Lee, T.T., Gray, J.M., Hillard, C.J., Gorzalka, B.B., Viau, V., Endogenous cannabinoid signaling is essential for stress adaptation. Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 9406–9411.
20. Huffman, J.W., Thompson, A.L., Wiley, J.L., Martin, B.R., Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940. Bioorg. Med. Chem. 16 (2008), 322–335.
21. Järbe, T.U., Lamb, R.J., Makriyannis, A., Lin, S., Goutopoulos, A., Delta-9-THC training dose as a determinant for (R)-methanandamide generalization in rats. Psychopharmacology (Berl.) 140 (1998), 519–522.
22. Järbe, T.U., Liu, Q., Makriyannis, A., Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats. Psychopharmacology (Berl.) 184 (2006), 36–45.
23. Jarbe, T.U., McMillan, D.E., Delta 9-THC as a discriminative stimulus in rats and pigeons: generalization to THC metabolites and SP-111. Psychopharmacology (Berl.) 71 (1980), 281–289.
24. Jarbe, T.U., LeMay, B.J., Halikhedkar, A., Wood, J., Vadivel, S.K., Zvonok, A., Makriyannis, A., Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats. Psychopharmacology (Berl.) 231 (2014), 489–500.
25. Lefever, T.W., Marusich, J.A., Antonazzo, K.R., Wiley, J.L., Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model. Pharmacol. Biochem. Behav. 118 (2014), 30–35.
26. Manera, C., Tuccinardi, T., Martinelli, A., Indoles and related compounds as cannabinoid ligands. Mini. Rev. Med. Chem. 8 (2008), 370–387.
27. Marusich, J.A., Lefever, T.W., Antonazzo, K.R., Craft, R.M., Wiley, J.L., Evaluation of sex differences in cannabinoid dependence. Drug Alcohol Depend. 137 (2014), 20–28.
28. Marusich, J.A., Craft, R.M., Lefever, T.W., Wiley, J.L., The impact of gonadal hormones on cannabinoid dependence. Exp. Clin. Psychopharmacol. 23 (2015), 206–216.
29. SAMHSA, Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. 2014, Substance Abuse and Mental Health Services Administration, Rockville, MD.
30. Schoenfeld, W.N., Cumming, W.W., Hearst, E., On the classification of reinforcement schedules. Proc. Natl. Acad. Sci. 42 (1956), 563–570.
31. Showalter, V.M., Compton, D.R., Martin, B.R., Abood, M.E., Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther. 278 (1996), 989–999.
32. Solinas, M., Goldberg, S.R., Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats. Psychopharmacology (Berl.) 179 (2005), 804–812.
33. Tait, R.J., Caldicott, D., Mountain, D., Hill, S.L., Lenton, S., A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin. Toxicol. (Phila.) 54 (2016), 1–13.
34. Thomas, B.F., Lefever, T.W., Cortes, R.A., Kovach, A.L., Cox, A.O., Patel, P.R., Pollard, G.T., Marusich, J.A., Kevin, R.A., Gamage, T.F., Wiley, J.L., Thermolytic degradation of synthetic cannabinoids: chemical exposures and pharmacological consequences. J. Pharmacol. Exp. Ther., 2017, 10.1124/jpet.116.238717 [Epub ahead of print].
35. Tseng, A.H., Craft, R.M., Sex differences in antinociceptive and motoric effects of cannabinoids. Eur. J. Pharmacol. 430 (2001), 41–47.
36. Tseng, A.H., Harding, J.W., Craft, R.M., Pharmacokinetic factors in sex differences in delta 9-tetrahydrocannabinol-induced behavioral effects in rats. Behav. Brain Res. 154 (2004), 77–83.
37. Vidourek, R.A., King, K.A., Burbage, M.L., Reasons for synthetic THC use among college students. J. Drug Educ. 43 (2013), 353–363.
38. Wiley, J.L., Burston, J.J., Sex differences in delta(9)-tetrahydrocannabinol metabolism and in vivo pharmacology following acute and repeated dosing in adolescent rats. Neurosci. Lett. 576 (2014), 51–55.
39. 9- tetrahydrocannabinol. Behav. Pharmacol. 4 (1993), 581–585.
40. Wiley, J.L., Lowe, J.A., Balster, R.L., Martin, B.R., Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 275 (1995), 1–6.
41. Wiley, J.L., Jefferson, R.G., Griffin, G., Liddle, J., Yu, S., Huffman, J.W., Martin, B.R., Paradoxical pharmacological effects of deoxy-tetrahydrocannabinol analogs lacking high CB1 receptor affinity. Pharmacology 66 (2002), 89–99.
42. Wiley, J.L., Marusich, J.A., Lefever, T.W., Cortes, R.A., Cross-substitution of delta-9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats. Pharmacol. Biochem. Behav. 124 (2014), 123–128.
43. Wiley, J.L., Walentiny, D.M., Wright, M.J. Jr., Beardsley, P.M., Burston, J.J., Poklis, J.L., Lichtman, A.H., Vann, R.E., Endocannabinoid contribution to delta(9)-tetrahydrocannabinol discrimination in rodents. Eur. J. Pharmacol. 737 (2014), 97–105.
44. Wiley, J.L., Owens, R.A., Lichtman, A.H., Discriminative stimulus properties of phytocannabinoids, endocannabinoids, and synthetic cannabinoids. Curr. Top. Behav. Neurosci., 2016 [Epub ahead of print].
45. Winsauer, P.J., Filipeanu, C.M., Bailey, E.M., Hulst, J.L., Sutton, J.L., Ovarian hormones and chronic administration during adolescence modify the discriminative stimulus effects of delta-9-tetrahydrocannabinol (Delta(9)-THC) in adult female rats. Pharmacol. Biochem. Behav. 102 (2012), 442–449.